Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Clinical and molecular associations with outcomes at two years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)

Garriga C. et al, (2021), Lancet rheumatology

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat med

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat med

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat med, 27, 279 - 288

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat med, 27, 270 - 278

Factors influencing the re-emergence of plague in Madagascar.

Alderson J. et al, (2020), Emerg top life sci, 4, 411 - 421

Multisystem inflammatory syndrome in children: getting to the heart of the matter.

Cavounidis A. et al, (2020), Nat rev immunol, 20

SARS-CoV-2: too infectious to handle?

Coveney C. and Alderson J., (2020), Nat rev immunol, 20

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.

von Loga IS. et al, (2019), Ann rheum dis, 78, 672 - 675

Include forthcoming?